On the recordJune 7, 2017
Is it appropriate to give pharmaceutical companies a $25-billion tax cut in the health-care reform bill when there is nothing to bring down the cost of prescription drugs in that bill?
Source
congress.govEditor's note · Context
Stabenow questions the appropriateness of tax cuts for pharma without lowering drug costs.
Share
More from Debbie Stabenow
Nov 18, 2024
Thank you so much. And thank you, Senator Klobuchar, for your current leadership and future leadership on the Committee on Agriculture, Nutrition, and Forestry. You know, I would say that, at any other time, putting forward a bill would be…
Sep 18, 2024
I love what you were saying about the fact that food at school should be no different than folding in the cost of riding the bus or some other service for children at school.
Other voices in this conversation
